StreetInsider.com News Articles

Form 4 Vaxcyte, Inc. For: Feb 26 Filed by: Cowan Elvia

Mon, 02 Mar 2026 20:09:00 -0500

si-local-file:///var/storage/secattach/20260302/26094724.html

Form 4 Vaxcyte, Inc. For: Feb 26 Filed by: Cowan Elvia

Mon, 02 Mar 2026 20:09:00 -0500

si-local-file:///var/storage/secattach/20260302/26094724.html

Form 4 Vaxcyte, Inc. For: Feb 26 Filed by: PICKERING GRANT

Mon, 02 Mar 2026 20:08:00 -0500

si-local-file:///var/storage/secattach/20260302/26094718.html

Form 4 Vaxcyte, Inc. For: Feb 26 Filed by: PICKERING GRANT

Mon, 02 Mar 2026 20:08:00 -0500

si-local-file:///var/storage/secattach/20260302/26094718.html

Form 4 Vaxcyte, Inc. For: Feb 26 Filed by: GUGGENHIME ANDREW

Mon, 02 Mar 2026 20:08:00 -0500

si-local-file:///var/storage/secattach/20260302/26094723.html

Form 4 Vaxcyte, Inc. For: Feb 26 Filed by: GUGGENHIME ANDREW

Mon, 02 Mar 2026 20:08:00 -0500

si-local-file:///var/storage/secattach/20260302/26094723.html

Form 4 Vaxcyte, Inc. For: Feb 26 Filed by: Wassil Jim

Mon, 02 Mar 2026 20:07:00 -0500

si-local-file:///var/storage/secattach/20260302/26094712.html

Form 4 Vaxcyte, Inc. For: Feb 26 Filed by: Wassil Jim

Mon, 02 Mar 2026 20:07:00 -0500

si-local-file:///var/storage/secattach/20260302/26094712.html

Form 4 Vaxcyte, Inc. For: Feb 26 Filed by: Dhaliwal Harpreet S.

Mon, 02 Mar 2026 20:07:00 -0500

si-local-file:///var/storage/secattach/20260302/26094715.html

Form 4 Vaxcyte, Inc. For: Feb 26 Filed by: Dhaliwal Harpreet S.

Mon, 02 Mar 2026 20:07:00 -0500

si-local-file:///var/storage/secattach/20260302/26094715.html

Vaxcyte (PCVX) PT Raised to $67 at Goldman Sachs

Thu, 26 Feb 2026 06:10:53 -0500

Goldman Sachs analyst Asad Haider raised the price target on Vaxcyte (NASDAQ: PCVX) to $67.00 (from $38.00) while maintaining a Neutral rating.

Vaxcyte (PCVX) PT Raised to $89 at BTIG

Wed, 25 Feb 2026 14:27:34 -0500

BTIG analyst Tom Shrader raised the price target on Vaxcyte (NASDAQ: PCVX) to $89.00 (from $85.00) while maintaining a Buy rating.

The analyst comments "4Q25 Update. Lots of Serotype Specific Details to Come, but the Vastly Broader Breadth of Pneumococcal Serotype Coverage Positions VAX-31 for a Competitive Edge. Increasing PT to $89."

Vaxcyte (PCVX) PT Raised to $89 at BTIG

Wed, 25 Feb 2026 14:27:34 -0500

BTIG analyst Tom Shrader raised the price target on Vaxcyte (NASDAQ: PCVX) to $89.00 (from $85.00) while maintaining a Buy rating.

Vaxcyte (PCVX) PT Raised to $75 at TD Cowen

Wed, 25 Feb 2026 09:19:19 -0500

TD Cowen analyst Tara Bancroft raised the price target on Vaxcyte (NASDAQ: PCVX) to $75.00 (from $70.00) while maintaining a rating.

Vaxcyte (PCVX) PT Raised to $82 at Leerink Partners

Wed, 25 Feb 2026 06:22:10 -0500

Leerink Partners analyst David Risinger raised the price target on Vaxcyte (NASDAQ: PCVX) to $82.00 (from $77.00) while maintaining a Outperform rating.

The analyst comments "PCVX reported 4Q25 results and provided corporate updates. Major new news is that the company plans to advance VAX-A1, its vaccine candidate targeting Group A Streptococcus, into Ph1 in 2026. We raised our DCF-derived PT from $77 to $82, driven by adding VAXA1 and making other model changes. We believe VAX-A1 has multi-billion dollar blockbuster potential, which we discussed in our January 12, 2025 report (Stepping on the GAS; Highlighting Underappreciated Pipeline Program). Reiterate OP rating.

Vaxcyte (PCVX) PT Raised to $82 at Leerink Partners

Wed, 25 Feb 2026 06:22:10 -0500

Leerink Partners analyst David Risinger raised the price target on Vaxcyte (NASDAQ: PCVX) to $82.00 (from $77.00) while maintaining a Outperform rating.

Form 8-K Vaxcyte, Inc. For: Feb 24

Tue, 24 Feb 2026 17:22:00 -0500

si-local-file:///var/storage/secattach/20260224/26053101.html

Form 8-K Vaxcyte, Inc. For: Feb 24

Tue, 24 Feb 2026 17:22:00 -0500

si-local-file:///var/storage/secattach/20260224/26053101.html

Form 424B5 Vaxcyte, Inc.

Tue, 24 Feb 2026 17:19:00 -0500

si-local-file:///var/storage/secattach/20260224/26053068.html

Form 424B5 Vaxcyte, Inc.

Tue, 24 Feb 2026 17:19:00 -0500

si-local-file:///var/storage/secattach/20260224/26053068.html

Form S-8 Vaxcyte, Inc.

Tue, 24 Feb 2026 17:17:00 -0500

si-local-file:///var/storage/secattach/20260224/26053033.html

Form S-8 Vaxcyte, Inc.

Tue, 24 Feb 2026 17:17:00 -0500

si-local-file:///var/storage/secattach/20260224/26053033.html

Vaxcyte, Inc. (PCVX) Misses Q4 EPS by $4.13

Tue, 24 Feb 2026 16:45:54 -0500

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($5.63), $4.13 worse than the analyst estimate of ($1.50).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

Form 10-K Vaxcyte, Inc. For: Dec 31

Tue, 24 Feb 2026 16:38:00 -0500

si-local-file:///var/storage/secattach/20260224/26052378.html

Form 10-K Vaxcyte, Inc. For: Dec 31

Tue, 24 Feb 2026 16:38:00 -0500

si-local-file:///var/storage/secattach/20260224/26052378.html